CRM Bulletin Issue 15: “Celebrating Clinical Trials” is out!

From CEO’s Desk

It is always an exciting time as we progress into the third quarter of each year because it is during this phase that we can see most of our efforts blossom into something of significance. At this juncture also, I would like to take this opportunity to highlight the fantastic achievements of our doctors in driving more high-quality clinical trials here in Malaysia. In recognising their contributions, we have held our annual Clinical Trials Day where we awarded them with the CRM Industry Sponsored Research Award – an award given to high achievers in clinical trials in Malaysia. We hope that with such awards, more people will step up their game in their respective fields.

As CRM is growing at a rapid pace, we recognise the importance of forging partnerships with global entities that are paving the way for better healthcare. To begin with, we have the National University Hospital Singapore (NUHS) team visiting the Director-General of Health, Datuk Dr. Noor Hisham in Malaysia. NUHS has also shown a strong interest to collaborate with Malaysia in clinical research and training. With this, we have reached another important milestone in our Phase 1 Realization Project. Next – with amazing help from our South Korean counterpart, C&R Research Inc. – the CRM team together with Datuk Dr. Noor Hisham went for a series of business networking meetings in Seoul. During the visit, we took the opportunity to promote Malaysia’s clinical research capabilities to the pharmaceutical companies in Korea in a bid to encourage them to conduct clinical trials here in Malaysia. I truly believe that by building trust with our current partners and expanding trust to our future partners, we will be able to position Malaysia as the site for sponsored research in this region.

As our faithful readers might know, one of our aims at CRM is to become a truly global research organisation. In line with our core values of Transparency, Honesty, Accountability & Trustworthiness, we strive to achieve the highest standards in the way we conduct our business.  As such, we are currently at the final phases of obtaining the ISO 9001:2015 accreditation, which we work very hard to obtain since last year. Being accredited with ISO 9001: 2015 will demonstrate the quality of management we are practicing within CRM and the consistent standard quality of clinical trials that are being conducted at all sites in Malaysia. We hope to achieve and obtain this accreditation by early 2019.

Finally, I would like to also take this opportunity to thank all of our people in CRM for striving hard in making the organisation a strong force it is today. For our readers, I hope you will enjoy reading this bulletin and will gain more insight on what we do, the kind of activities we conduct and most importantly, appreciate the efforts the whole community is putting in to make our world a better place to live in.

Dr. Akhmal Yusof
CEO, Clinical Research Malaysia